Literature DB >> 6148299

Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis.

B Nalpas, A Vassault, A Le Guillou, B Lesgourgues, N Ferry, B Lacour, P Berthelot.   

Abstract

Serum activity of the mitochondrial isoenzyme of aspartate aminotransferase (mAST) was measured with an immunological method in 74 subjects. Fourty-six were chronic alcoholics with (30) or without (16) obvious alcoholic liver disease; 28 were nonalcoholic controls among whom 14 had acute or chronic viral hepatitis, the remaining 14 being healthy individuals. Mean mAST activity was much higher in all the alcoholic subjects, with or without liver disease, 10.4 and 1.95 units per liter, respectively, than in the healthy controls (0.43, p less than 0.001). The mean mAST to total AST ratio was similar in the healthy controls and in the patients with viral hepatitis (2.98 and 3.19%, NS), whereas it was about 4 times higher in the alcoholics with a sensitivity which reached 93% in the patients with alcoholic liver disease and 100% in those without. Both gamma-glutamyl transpeptidase and glutamate dehydrogenase serum activities were far less sensitive and specific. As almost all chronic alcoholics had similar abnormal values of mAST/total AST ratio, this leads to question whether "normal" liver may really exist in any of such subjects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148299     DOI: 10.1002/hep.1840040517

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

1.  Correlation of aspartate aminotransferase/platelet ratio index with hepatic venous pressure gradient in cirrhosis.

Authors:  Vipin Verma; Shiv Kumar Sarin; Praveen Sharma; Ashish Kumar
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

2.  The significance of serum mitochondrial aspartate aminotransferase activity in the surgical field.

Authors:  E Sada; S Tashiro; Y Morino
Journal:  Jpn J Surg       Date:  1991-01

3.  A diagnostic approach to different types of non-A non-B acute hepatitis through the evaluation of the lobular distribution of hepatocytic damage.

Authors:  S Takase; A Takada; H Sato
Journal:  Gastroenterol Jpn       Date:  1990-02

Review 4.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

5.  The significance of serum mitochondrial aspartate aminotransferase activity in obstructive jaundice: experimental and clinical studies.

Authors:  E Sada; S Tashiro; Y Morino
Journal:  Jpn J Surg       Date:  1990-07

Review 6.  Gastrointestinal and Hepatic Manifestations of Ebola Virus Infection.

Authors:  Nisha Sharma; Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

Review 7.  The de ritis ratio: the test of time.

Authors:  Mona Botros; Kenneth A Sikaris
Journal:  Clin Biochem Rev       Date:  2013-11

8.  Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan.

Authors:  Ya-Ling Chen; Li-Ju Chen; Ming-Jong Bair; Mei-Lan Yao; Hsiang-Chi Peng; Sien-Sing Yang; Suh-Ching Yang
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

9.  Prevention of hazardous drinking: the value of laboratory tests.

Authors:  R D Johnson; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

10.  Aspartate aminotransferase-immunoglobulin complexes in patients with chronic liver disease.

Authors:  Masahiko Tameda; Katsuya Shiraki; Kinue Ooi; Koujirou Takase; Yoshitane Kosaka; Tsutomu Nobori; Yukihiko Tameda
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.